Retrograde ejaculation following single-level anterior lumbar surgery with or without recombinant human bone morphogenetic protein–2 in 5 randomized controlled trials

Clinical article

View More View Less
  • 1 Wilderness Spine Services, Columbus, Georgia;
  • 2 Central Texas Spine Institute, Austin; and
  • 3 Center for Spine Care, Physicians Medical Center of Dallas, Texas
Restricted access

Purchase Now

USD  $45.00

Spine - 1 year subscription bundle (Individuals Only)

USD  $369.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00
Print or Print + Online

Object

The aim of this study was to determine the incidence and assess specific risk factors in the postoperative development of retrograde ejaculation (RE) in men treated for degenerative lumbar disc disease at the L4–5 or L5–S1 level with stand-alone anterior interbody implants with or without recombinant human bone morphogenetic protein–2 (rhBMP-2).

Methods

Patients enrolled in 5 prospective, randomized, multicenter FDA-approved investigational device exemption studies were observed for a minimum of 2 years to assess the rate of RE. Five hundred eight men with symptomatic single-level lumbar degenerative disc disease with up to Grade 1 spondylolisthesis underwent anterior lumbar interbody surgery with stand-alone anterior implants at either L4–5 or L5–S1. All patient self-reported and physician-documented adverse events were recorded over the entire course of follow-up. In the investigational groups, 207 patients were treated with an open surgical procedure using dual paired constructs and rhBMP-2 on an absorbable collagen sponge. The control groups (n = 301) were treated with lumbar fusion cage implants and iliac crest autograft or a metal-on-metal disc arthroplasty device. Multivariate analyses of RE were performed to assess the influence of treatment (rhBMP-2), surgical approach, and treated level. Data were analyzed for each trial individually and for the data pooled from the 5 trials.

Results

Retrograde ejaculation occurred at the highest rates in the earliest clinical trial. Of the 146 men, 6 (4.1%) developed RE postoperatively. In subsequent studies, the rates of RE ranged from 0% to 2.1%. Combining the data from the 5 trials, RE was reported in 7 (3.4%) of the 207 patients who received the rhBMP-2 treatment compared with 5 (1.7%) of the 301 patients who received the autograft or lumbar disc treatment (p = 0.242, Fisher exact test). Cases of RE were reported in 7 (1.6%) of 445 patients who underwent a retroperitoneal spinal exposure; 5 RE cases were reported in 58 patients (8.6%) who underwent a transperitoneal approach. The difference in surgical approaches was significant (p = 0.007, Fisher exact test). There was no difference in the rate of RE based on the lumbar level exposed (p = 0.739). Multivariate analyses were consistent with the conclusions from Fisher exact tests. In the initial rhBMP-2 trial, after adjusting for effects of surgical approach and treated level, the difference in RE between the treatment groups (rhBMP-2 vs autograft or disc arthroplasty) was not significant (p = 0.177); however, the difference in RE between the retroperitoneal and transperitoneal approaches was significant (p = 0.029).

Conclusions

In these 5 prospective randomized trials involving anterior lumbar interbody surgery, the use of rhBMP-2 was associated with a higher incidence of RE (3.4% vs 1.7%) but did not reach statistical significance. Based on surgical approach, the difference in rates of RE was statistically significant. This study reports on the outcomes of 5 prospective randomized FDA-approved investigational device exemption trials. Registration for studies became law in 2007. Four of these trials were completed before the law went into effect. The registration number for the lumbar disc arthroplasty trial is NCT00635843.

Abbreviations used in this paper:ACS = absorbable collagen sponge; ALIF = anterior lumbar interbody fusion; ICBG = iliac crest bone graft; IDE = investigational device exemption; RCT = randomized controlled trial; RE = retrograde ejaculation; rhBMP-2 = recombinant human bone morphogenetic protein–2; TDR = total disc replacement.

Spine - 1 year subscription bundle (Individuals Only)

USD  $369.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00

Contributor Notes

Address correspondence to: J. Kenneth Burkus, M.D., 6262 Veterans Parkway, Columbus, Georgia 31908-9517. email: jkb66@knology.net.

Please include this information when citing this paper: published online November 30, 2012; DOI: 10.3171/2012.10.SPINE11908.

  • 1

    Birch N, & Shaw M: Retrograde ejaculation after anterior lumbar interbody fusion. Spine (Phila Pa 1976) 29:106107, 2004

  • 2

    Blumenthal S, , McAfee PC, , Guyer RD, , Hochschuler SH, , Geisler FH, & Holt RT, : A prospective, randomized, multicenter Food and Drug Administration investigational device exemptions study of lumbar total disc replacement with the CHARITE artificial disc versus lumbar fusion: part I: evaluation of clinical outcomes. Spine (Phila Pa 1976) 30:15651575, 2005

    • Search Google Scholar
    • Export Citation
  • 3

    Burkus JK: Bone morphogenetic proteins in anterior lumbar interbody fusion: old techniques and new technologies. Invited submission from the Joint Section Meeting on Disorders of the Spine and Peripheral Nerves, March 2004. J Neurosurg Spine 1:254260, 2004

    • Search Google Scholar
    • Export Citation
  • 4

    Burkus JK: Surgical treatment of the painful motion segment: matching technology with indications. Spine (Phila Pa 1976) 30:16 Suppl S7S15, 2005

    • Search Google Scholar
    • Export Citation
  • 5

    Burkus JK, , Gornet MF, , Dickman CA, & Zdeblick TA: Anterior lumbar interbody fusion using rhBMP-2 with tapered interbody cages. J Spinal Disord Tech 15:337349, 2002

    • Search Google Scholar
    • Export Citation
  • 6

    Burkus JK, , Gornet MF, , Schuler TC, , Kleeman TJ, & Zdeblick TA: Six-year outcomes of anterior lumbar interbody arthrodesis with use of interbody fusion cages and recombinant human bone morphogenetic protein-2. J Bone Joint Surg Am 91:11811189, 2009

    • Search Google Scholar
    • Export Citation
  • 7

    Burkus JK, , Sandhu HS, , Gornet MF, & Longley MC: Use of rhBMP-2 in combination with structural cortical allografts: clinical and radiographic outcomes in anterior lumbar spinal surgery. J Bone Joint Surg Am 87:12051212, 2005

    • Search Google Scholar
    • Export Citation
  • 8

    Burkus JK, , Transfeldt EE, , Kitchel SH, , Watkins RG, & Balderston RA: Clinical and radiographic outcomes of anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2. Spine (Phila Pa 1976) 27:23962408, 2002

    • Search Google Scholar
    • Export Citation
  • 9

    Carragee E, & Wildstein M: A controlled trial of BMP and unilateral transpedicular instrumentation in circumferential single or double level lumbar fusion. Spine J 7:Suppl 8S9S, 2007

    • Search Google Scholar
    • Export Citation
  • 10

    Carragee EJ, , Mitsunaga KA, , Hurwitz EL, & Scuderi GJ: Retrograde ejaculation after anterior lumbar interbody fusion using rhBMP-2: a cohort controlled study. Spine J 11:511516, 2011

    • Search Google Scholar
    • Export Citation
  • 11

    Escobar E, , Transfeldt E, , Garvey T, , Ogilvie J, , Graber J, & Schultz L: Video-assisted versus open anterior lumbar spine fusion surgery: a comparison of four techniques and complications in 135 patients. Spine (Phila Pa 1976) 28:729732, 2003

    • Search Google Scholar
    • Export Citation
  • 12

    Gornet MF, , Burkus JK, , Dryer RF, & Peloza JH: Lumbar disc arthroplasty with MAVERICK disc versus stand-alone interbody fusion: a prospective, randomized, controlled, multicenter investigational device exemption trial. Spine (Phila Pa 1976) 36:E1600E1611, 2011

    • Search Google Scholar
    • Export Citation
  • 13

    Kaiser MG, , Haid RW Jr, , Subach BR, , Miller JS, , Smith CD, & Rodts GE Jr: Comparison of the mini-open versus laparoscopic approach for anterior lumbar interbody fusion: a retrospective review. Neurosurgery 51:97105, 2002

    • Search Google Scholar
    • Export Citation
  • 14

    Kleeman TJ, , Ahn UM, & Talbot-Kleeman A: Laparoscopic anterior lumbar interbody fusion with rhBMP-2: a prospective study of clinical and radiographic outcomes. Spine (Phila Pa 1976) 26:27512756, 2001

    • Search Google Scholar
    • Export Citation
  • 15

    Li J, , Dumonski ML, , Liu Q, , Lipman A, , Hong J, & Yang N, : A multicenter study to evaluate the safety and efficacy of a stand-alone anterior carbon I/F Cage for anterior lumbar interbody fusion: two-year results from a Food and Drug Administration investigational device exemption clinical trial. Spine (Phila Pa 1976) 35:E1564E1570, 2010

    • Search Google Scholar
    • Export Citation
  • 16

    Lieberman IH, , Willsher PC, , Litwin DEM, , Salo PT, & Kraetschmer BG: Transperitoneal laparoscopic exposure for lumbar interbody fusion. Spine (Phila Pa 1976) 25:509515, 2000

    • Search Google Scholar
    • Export Citation
  • 17

    Regan JJ, , McAfee PC, , Blumenthal SL, , Guyer RD, , Geisler FH, & Garcia R Jr, : Evaluation of surgical volume and the early experience with lumbar total disc replacement as part of the investigational device exemption study of the Charité Artificial Disc. Spine (Phila Pa 1976) 31:22702276, 2006

    • Search Google Scholar
    • Export Citation
  • 18

    Sasso RC, , Best NM, , Mummaneni PV, , Reilly TM, & Hussain SM: Analysis of operative complications in a series of 471 anterior lumbar interbody fusion procedures. Spine (Phila Pa 1976) 30:670674, 2005

    • Search Google Scholar
    • Export Citation
  • 19

    Sasso RC, , Burkus JK, & LeHuec JC: Retrograde ejaculation after anterior lumbar interbody fusion: transperitoneal versus retroperitoneal exposure. Spine (Phila Pa 1976) 28:10231026, 2003

    • Search Google Scholar
    • Export Citation
  • 20

    Sasso RC, , Kitchel SH, & Dawson EG: A prospective, randomized controlled clinical trial of anterior lumbar interbody fusion using a titanium cylindrical threaded fusion device. Spine (Phila Pa 1976) 29:113122, 2004

    • Search Google Scholar
    • Export Citation
  • 21

    Smoljanovic T, , Bojanic I, & Rakovac M: Re: Sasso RC, Burkus JK, LeHuec JC. Retrograde ejaculation after anterior lumbar interbody fusion: transperitoneal versus retroperitoneal exposure. Spine (Phila Pa 1976) 35:E622E623, 2010

    • Search Google Scholar
    • Export Citation
  • 22

    Smoljanovic T, , Rakovac M, & Bojanic I: Could chronic host inflammatory response be responsible for delayed onset of retrograde ejaculation after the labeled use of recombinant human bone morphogenetic protein-2?. Spine J 11:167168, 2011

    • Search Google Scholar
    • Export Citation
  • 23

    Smoljanovic T, , Siric F, & Bojanic I: Six-year outcomes of anterior lumbar interbody arthrodesis with use of interbody fusion cages and recombinant human bone morphogenetic protein-2. J Bone Joint Surg Am 92:26142616, 2010

    • Search Google Scholar
    • Export Citation
  • 24

    Swan J, , Hurwitz E, , Malek F, , van den Haak E, , Cheng I, & Alamin T, : Surgical treatment for unstable low-grade isthmic spondylolisthesis in adults: a prospective controlled study of posterior instrumented fusion compared with combined anterior-posterior fusion. Spine J 6:606614, 2006

    • Search Google Scholar
    • Export Citation
  • 25

    Zigler J, , Delamarter R, , Spivak JM, , Linovitz RJ, , Danielson GO III, & Haider TT, : Results of the prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of the ProDisc-L total disc replacement versus circumferential fusion for the treatment of 1-level degenerative disc disease. Spine (Phila Pa 1976) 32:11551163, 2007

    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 1123 325 22
Full Text Views 152 28 0
PDF Downloads 182 23 0
EPUB Downloads 0 0 0